TriNetX operates a web-based platform that gives researchers on-demand access to harmonized clinical and claims data mapped to controlled terminology, with a suite of analytics for trial design, site selection and RWE generation. The network aggregates global clinical and claims data representing over 300 million patients from hundreds of healthcare organizations, including deep specialty data and linked medical and pharmacy claims and EMR data. Its platform is powered by a network of healthcare organizations across 17 countries, including the US, UK, Germany, Italy, Japan, Singapore, India and Brazil. Since commercialization, TriNetX's customer base has expanded to 29 industry customers, including nine of the top 15 pharmaceutical companies and five of the top contract research organizations. The company is led by CEO Gadi Lachman. TriNetX intends to use new funds to accelerate international expansion in Europe, Asia and South America and to further develop its analytics platform, particularly in AI, machine learning and digital clinical trials.

Total raised

$40M

Funding rounds

1

Latest round

Series D

Latest activity

Mar 2019